PROGNOSTIC RELEVANCE OF MIR-422A IN HEAD AND NECK SQUAMOUS CELL CARCINOMA Application WO-2017207690-A1 World Intellectual Property Organisation (WIPO) 07 Dec 2017
METHOD FOR PREDICTING SENSITIVITY OF OSTEOSARCOMA PATIENT TO ANTICANCER AGENT Application EP-2930248-A1 European Patent Office 14 Oct 2015